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Inactivation of the subunit of the calcium channel in the mouse neurological mutant lethargic results in a complexb4
neurological disorder that includes absence epilepsy and ataxia. To determine the role of the calcium-channel b4-
subunit gene CACNB4 on chromosome 2q22-23 in related human disorders, we screened for mutations in small
pedigrees with familial epilepsy and ataxia. The premature-termination mutation R482X was identified in a patient
with juvenile myoclonic epilepsy. The R482X protein lacks the 38 C-terminal amino acids containing part of an
interaction domain for the subunit. The missense mutation C104F was identified both in a German family witha1
generalized epilepsy and praxis-induced seizures and in a French Canadian family with episodic ataxia. These coding
mutations were not detected in 255 unaffected control individuals (510 chromosomes), and they may be considered
candidate disease mutations. The results of functional tests of the truncated protein R482X in Xenopus laevis
oocytes demonstrated a small decrease in the fast time constant for inactivation of the cotransfected subunit.a1
Further studies will be required to evaluate the in vivo consequences of these mutations. We also describe eight
noncoding single-nucleotide substitutions, two of which are present at polymorphic frequency, and a previously
unrecognized first intron of CACNB4 that interrupts exon 1 at codon 21.
Introduction
Inherited movement and seizure disorders are a major
clinical burden, the molecular etiology of which re-
mains, for the most part, undefined. The results of
recent studies have indicated that mutations in the
neuronal voltage-gated ion channels are a major con-
tributor to these conditions (Cooper and Jan 1999;
McNamara 1999). Mutations in five neuronal ion-
channel genes have been associated with idiopathic
epilepsies. These mutations are found in the a and
subunits of the voltage-gated sodium channel inb1
generalized epilepsy with febrile seizures plus
(GEFS1) (Wallace et al. 1998; Escayg et al. 2000), in
the potassium-channel genes KCNQ2 and KCNQ3 in
benign familial neonatal convulsions (Biervert et al.
1998; Charlier et al. 1998; Singh et al. 1998), and in
the subunit of the neuronal nicotinic acetylcholinea4
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receptor in autosomal dominant nocturnal frontal-
lobe epilepsy (Steinlein et al. 1995). The voltage-gated
sodium-channel gene SCN5A has also been implicated
in the seizure activity of individuals with LQT3 (Hart-
mann et al. 1999). With regard to ion channels and
ataxia, the potassium-channel gene KCNA1 and the
calcium-channel gene CACNA1A are associated with
episodic ataxia type 1 and type 2, respectively. Other
alleles of CACNA1A cause spinocerebellar ataxia type
6 and familial hemiplegic migraine, demonstrating
that different mutations in the same ion-channel gene
can produce different neurological phenotypes. In the
mouse, allelic mutations in the sodium-channel gene
SCN8A result in ataxia, dystonia, and paralysis
(Meisler et al. 1997; Sprunger et al. 1999), and several
other mouse neurological mutants have been associ-
ated with ion channels (Burgess and Noebels 1999).
The voltage-gated calcium channels play a critical role
in neurotransmitter release in neurons. Calcium chan-
nels are multimeric proteins that contain an subunita1
with pore-forming domains and the auxiliary subunits
b, g, and a2d (Perez-Reyes and Schneider 1994). At least
seven distinct mammalian genes encoding calcium-
channel subunits have been identified. Four paralo-a1
gous genes encoding the b subunits – have beenb b1 4
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mapped to conserved chromosome segments in human
and mouse (Plummer and Meisler 1999). Interaction of
and b subunits contributes to the diversity of calciuma1
currents by modulation of current amplitude, voltage
dependence, and kinetics of activation and inactivation
(De Waard and Campbell 1995). The b subunits also
appear to participate in the membrane trafficking of the
subunit (Yamaguchi et al. 1998; Gerster et al. 1999).a1
The amino acid sequences of the four mammalian b
subunits differ by ∼20%. All b subunits are expressed
in the brain, with regional differences in the levels of
expression. The subunit is the most highly expressedb4
subunit in the cerebellum (Burgess et al. 1999).
We demonstrated that a null mutation in the b4
subunit is responsible for an autosomal recessive neu-
rological disorder in the mouse mutant lethargic (Bur-
gess et al. 1997). A 4-bp insertion into a splice-donor
site results in exon skipping and premature termi-
nation of the protein upstream of the major site for
interaction with the subunit. Absence of b4-subunita1
protein in lethargic brain has been confirmed with
the use of specific antisera (McEnery et al. 1998). The
lack of subunits results in severe ataxia, focal mo-b4
tor abnormalities, and brief periods of behavioral im-
mobility that are accompanied by bilaterally syn-
chronous, generalized cortical spike-wave discharges
with a mean duration of 1.5 s and a frequency of
100/h (Hosford et al. 1992). These spontaneous ab-
sence seizures share behavioral, electrographic, and
pharmacological responses with absence seizures in
patients (Hosford et al. 1999). The -subunit defi-b4
ciency results in a selective decrease in excitatory syn-
aptic transmission in somatosensory thalamic neu-
rons (Caddick et al. 1999). Despite the compensatory
association of -subunit proteins with other b sub-a1
units (Burgess et al. 1999), only 20% of lethargic
homozygotes survive beyond weaning.
To determine the effects of mutations in the human
orthologue of lethargic, we characterized the exon
structure of the human calcium-channel b4-subunit
gene (CACNB4 [MIM 601949]) and mapped the gene
to chromosome 2q22-23 (Escayg et al. 1998). Genes
for two epilepsy syndromes—generalized epilepsy
with febrile seizures plus (GEFS1) and febrile sei-
zures (FEB3)—have recently been mapped to this
chromosome region (Baulac et al. 1999; Moulard et
al. 1999; Peiffer et al. 1999; Lopez-Cendes et al.
2000). In each family, one or two recombinants
placed the disease gene distal to markers D2S141 and
D2S284. Since we mapped CACNB4 proximal to
these markers on the GB4 radiation-hybrid panel, it
is apparently excluded as a candidate gene (Escayg
et al. 1998). We now report the results of screening
for CACNB4 mutations in affected individuals from
small pedigrees with common subtypes of idiopathic
generalized epilepsy and hereditary episodic ataxia.
The results of exon amplification and conformation-
sensitive gel electrophoresis (CSGE) revealed several
noncoding polymorphic variants and two coding mu-
tations in affected individuals.
Material and Methods
Mutation Detection
The 14 exons of CACNB4 were individually amplified
from genomic DNA, by use of primers designed from
intron sequences. PCR amplification was performed for
32 cycles of 1 min at 947C, 45 s at 607C, and 1 min at
727C. PCR products were incubated for 10 min at 997C,
followed by 30 min at 687C to facilitate heteroduplex
formation, and they were analyzed by CSGE, as de-
scribed elsewhere (Raman et al. 1997). Exons with elec-
trophoretic variants were reamplified, PCR products
were purified from agarose gels by use of the Qiaex II
gel extraction kit (Qiagen), and manual sequencing was
performed with use of the Thermo Sequenase sequencing
kit (USB).
Patients
DNA was obtained from index patients from 90 fam-
ilies with idiopathic generalized epilepsy (Sander et al.
1999) and from 71 families with episodic ataxia. The
families with epilepsy included 19 families with child-
hood absence epilepsy, 22 with juvenile absence epilepsy,
and 49 with juvenile myoclonic epilepsy (JME). More
than 250 unrelated controls were tested for variants de-
tected in the affected individuals. The clinical features
of pedigrees with coding variants of CACNB4 are de-
scribed in the Appendix. Informed consent was obtained
from all participants.
Functional Tests in Xenopus laevis Oocytes
The mutations R482X and C104F were introduced
into the previously described rat -subunit cDNA (Wal-b4
ker et al. 1998). The rat and human CACNB4 proteins
exhibit 99% sequence identity (512/519 amino acids;
Escayg et al. 1998), and human residue C104 corre-
sponds to rat C103. R482X was constructed by means
of PCR amplification of the corresponding region of the
wild-type cDNA with the addition of a Kozak sequence
and a termination codon. The PCR product was sub-
cloned into pcDNA3, with the use of HindIII and BamHI
sites added to the PCR primers. The C104F mutation
was introduced by use of the QuickChange site-directed
mutagenesis kit (Stratagene) with the following muta-
genic primers: 5′-AAA ACG AAT GTG AGC TAC TTT
GGT GCC CTG GAT GAG GAT GTG-3′ (forward) and
5′-CAC ATC CTC ATC CAG GGC ACC AAA GTA
GCT CAC ATT CGT TTT CAC-3′ (reverse). Oocytes
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Figure 1 Structure and interactions of CACNB4. A, Intron/exon
junctions for exons 1A and 1B. The indicated 5′ end of exon 1A
corresponds to the translation-initiation site. The intron sequence is
from GenBank (accession number AF216867). B, Locations of mu-
tations in CACNB4. Two domains of CACNB4 that interact with the
a1 subunit of the voltage-gated calcium channel are indicated. In the
mouse lethargic mutant (designated as “lh”), the protein is truncated
upstream of the major binding site. In human mutation R482X, the
protein is truncated in the middle of a domain that interacts with the
C-terminus of the a1A subunit.
Table 1












Exon 9 762 T/A !.01 9F: CTG GCT TGT TCT GTT CTG TG 9R: GCA CAG CTT GAA GAA GTA CC
Exon 12 1239 G/A .03 12F: AAC TGC CCA TAT AGC ACC TC 12R: TCC ATC CTA ATC AAG AAG TTC CC
Exon 13 1413 G/A !.01 13F: GCA TCT TAT TGT ACA GAT CC 13R: GCT ATC TTA GCC AAG TTA AG
Exon 13 1567 T/C !.01 13F: GCA TCT TAT TGT ACA GAT CC 13R: GCT ATC TTA GCC AAG TTA AG
Intron 2 268 237 C/T .01 3F: CAT TTG AGA TCC CTC TTT GG 3R: GTT TGG CTC AGA GCT GAT TC
Intron 3 3901 22 T/C !.01 3F: CAT TTG AGA TCC CTC TTT GG 3R: GTT TGG CTC AGA GCT GAT TC
Intron 5 599 215 G/A !.01 6F: AGG GAC AAA TGG GTA CAT TC 7R: GGG TGC TCG ATC AAG AAC TG
Intron 6 619 224 C/T !.01 6F: AGG GAC AAA TGG GTA CAT TC 7R: GGG TGC TCG ATC AAG AAC TG
Coding:
Exon 3 (C104F) 311 G/T !.006 3F: CAT TTG AGA TCC CTC TTT GG 3R: GTT TGG CTC AGA GCT GAT TC
Exon 13 (R482X) 1444 C/T !.006 13F: GCA TCT TAT TGT ACA GAT CC 13R: GCT ATC TTA GCC AAG TTA AG
a Nucleotide positions are based on the cDNA sequence (GenBank accession number AF038852; Escayg et al. 1998).
b Frequencies are based on the results of analysis of 500–1,000 chromosomes.
were injected with each -subunit mRNA (0.1 mg/ml),b4
in combination with the -subunit gene CACNA1Aa1
(0.4 mg/ml). Electrophysiological recordings were per-
formed 4–5 d after injection, as described elsewhere
(Walker et al.1998).
Results
An Additional Intron in CACNB4
We have previously reported that the CACNB4 coding
sequence is interrupted by 12 introns at positions cor-
responding to the introns of the human CACNB3 gene
(Escayg et al. 1998). Amplification of genomic DNA, by
use of primers from the 5′ untranslated region and intron
1, generated a product that was 0.5 kb longer than that
which was predicted by the cDNA. Sequence analysis
identified a small intron (535 bp) that interrupts exon
1 (GenBank accession number AF216867). The first two
exons of CACNB4 are now designated as “1A” and
“1B” (fig. 1A).
Noncoding Variation in CACNB4
Eight noncoding variants were identified by CSGE
analysis of exons amplified from genomic DNA (table
1). Two of these noncoding variants are present at poly-
morphic frequencies >1%, whereas the others are rare
variants.
Premature-Termination Mutation in a Family with JME
The proband in pedigree A (individual I-1; fig. 2A)
exhibited JME. Her symptoms include characteristic
bilateral myoclonic jerks of the shoulders and arms
without loss of consciousness, sporadic absence sei-
zures, and generalized tonic-clonic seizures (GTCS).
A unique conformer of exon 13 was observed in in-
dividual I-1, by means of CSGE (fig. 2B, lane 1).
Sequencing demonstrated heterozygosity for a CrT
transition (fig. 2C). This mutation generates a pre-
mature stop codon (R482X) and eliminates 38 amino
acids comprising the C-terminal 10% of the protein.
This mutation can also be detected by generation of
a novel AluI site (fig. 2D).
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Figure 2 R482X mutation in a family with JME. A, Affected individuals (blackened symbols) are shown, with the arrow pointing to the
proband. B, Results of CSGE of exon 13. A unique band seen in the proband (lane 1, arrow) is not observed in three unrelated controls (lanes
2–4). C, The sequence of exon 13 demonstrates that the proband is heterozygous for a CrT transition that generates the premature-termination
codon R482X. D, Results of a restriction-site assay for R482X. A 388-bp fragment obtained by digestion of wild-type exon 13 with AluI is
shown (lanes 2–4). The internal AluI site produced by R482X results in two fragments (209 bp and 179 bp; see lane 1).
Individual II-3 is considered to be affected, on the
basis of an abnormal electroencephalogram (EEG) with
generalized 3/s spike-wave discharges (for clinical de-
tails, see the Appendix). To date, efforts to obtain DNA
samples from individuals I-2 and II-1 have not been
successful.
Segregation of C104F in Two Pedigrees with Different
Neurological Phenotypes
The proband in pedigree B (individual I-1; fig. 3A)
and his son (individual II-3) exhibit idiopathic gener-
alized epilepsy with rare GTCS, atypical absence sei-
zures, and evidence of an unusual cognitive trigger of
seizure initiation. An exon 3 variant was detected, by
means of CSGE, in both affected individuals (fig 3C,
left). The results of sequence analysis demonstrated het-
erozygosity for a GrT transversion (fig. 3D) resulting
in the replacement of cysteine residue 104 by phenyl-
alanine (C104F). The unaffected members of family B
do not carry the mutation.
C104F was also observed in an unrelated French Ca-
nadian family with episodic ataxia (pedigree C; fig. 3B
and C). In this family, five affected and two asympto-
matic individuals carry the C104F mutation, consistent
with incomplete penetrance (70%) if this is a causal
mutation.
Analysis of R482X and C104F in Control Samples
We analyzed exon 3 and exon 13 in 255 control sam-
ples (510 chromosomes), including 133 asymptomatic
individuals of northern European origin (Sander et al.
1999) and 80 CEPH parents. R482X and C104F were
not present in the controls, indicating that the allele fre-
quencies for both mutations are !.006 (95% confidence
level).
Functional Analysis of R482X and C104F in Xenopus
Oocytes
To evaluate their effects on channel properties, the
mutations R482X and C104F were introduced into the
rat -subunit cDNA and were coexpressed with theb4
-subunit in Xenopus oocytes. Expression of the wild-a1A
type subunit together with the subunit producesb a4 1A
a slowly inactivating inward current (fig. 4a). This21Ba
current is not seen in the absence of the subunit. Bothb4
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Figure 3 C104F mutation cosegregating with neurological disease in two unrelated pedigrees. A, Pedigree B, which is of German origin
and exhibits idiopathic generalized epilepsy. B, Pedigree C, which is of French Canadian origin and exhibits episodic ataxia. C, CSGE analysis
of exon 3 from pedigree B (left) and from pedigree C (right). The variant conformer is indicated (arrow). Numbers above the lanes correspond
to individuals in the pedigrees. D, Sequence of exon 3 that demonstrates a GrT transversion that changes the wild-type cysteine 104 codon
to phenylalanine. CACNB4 genotypes are indicated below the symbols. G = allele 1; T = allele 2.
mutants were able to associate with the subunit, toa1A
produce inward currents (fig. 4a). Increases in current
density of 1.4-fold and 1.3-fold were observed for
R482X and C104F, respectively (fig. 4b). There was no
change in the voltage dependence of activation.
An interesting change in the kinetics of inactivation
was observed for the truncated R482X mutant. The
wild-type subunit produces biphasic inactivationb4
(Walker et al. 1998) with a fast-inactivating component
(F), a slower inactivating component (S), and a noni-
nactivating component (NI). For test potentials of 0–20
mV, the F component for the R482X mutant is accel-
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Figure 4 Electrophysiological analysis of mutant subunits. Xenopus oocytes were injected with mRNA from either the wild-type orb4
mutant subunit, in combination with the CACNA1A subunit. A, Sets of current traces at test potentials of 220, 210, 0, 10, 20, and 30b a4 1
mV. The potential of half-activation was not significantly modified by the mutations, with mV ( -subunit R482X, ),V =212.2 5 0.9 b n = 81/2 4
mV ( -subunit C104F; ), and mV (wild-type subunit; ). There was a small shift in the voltage dependence211.3 5 0.6 b n = 8 210 5 0.1 b n = 84 4
of inactivation of the -subunit R482X, with half-inactivation potentials of mV ( -subunit R482X; ) anda b V = 241.1 5 0.4 b n = 7 V =1A 4 1/2 4 1/2
(wild-type subunit; ,). B, Average current density generated by wild-type and mutant channels at a membrane depolarization237.4 5 0.5 b n = 64
of 0 mV (peak current amplitude for each subunit combination). The average current density of the wild-type subunit ( mA/a b 1.90 5 0.151A 4
mF; ) at 0 mV was increased 1.4- and 1.3-fold, to ( ) and ( ), with -subunit R482X and -subunitn = 8 2.72 5 0.25 n = 8 2.45 5 0.24 n = 8 b b4 4
C104F, respectively. Asterisks (*) denote statistical significance (t test ; ). C, Average time constants for the fast component of inactivation.P ≤ .1
At a membrane depolarization of 10 mV, the wild-type current inactivates along three components, a fast-inactivating component (F) with an
average time constant of ms ( ), which constitutes % of the total current, a slower inactivating component (S) with89.6 5 5.3 n = 7 19.9 5 3.4
an average time constant of ms ( %), and a noninactivating (NI) component ( %). With -subunit R482X, there323 5 37.4 73.9 5 3.1 6.2 5 0.9 b4
was no change in the proportion of each component, but the F component demonstrated a faster rate of decrease ( ms; ). The50.7 5 4.7 n = 6
time constants for -subunit R482X at 0 and 10 mV are statistically significantly different from those for wild type ( ). Values are meanb P ! .014
5 SEM.
erated. For example, at 10 mV, the time constant for
R482X is ms, compared with ms50.7 5 4.7 89.6 5 5.3
for the wild-type subunit (fig. 4c). This change isb4
similar to that previously observed for constructs with
deletions of the C-terminus (Walker et al. 1998). No
kinetic alteration was observed for the C104F mutation
(fig. 4c and data not shown).
Discussion
The calcium-channel subunit is a highly conservedb4
protein, with 99% sequence identity between human
and rat (Escayg et al. 1998). We observed a very low
level of polymorphism in this initial study of human
variation. In addition to several noncoding polymor-
phisms in CACNB4, we identified two coding changes
that are potential disease mutations. The positions of
these mutations and the mouse lethargic mutation are
shown in figure 1B.
The N- and C-terminal portions of the and b sub-a1
units contain several functional domains that modulate
channel kinetics (Wei et al. 1994; de Leon et al. 1995;
Tareilus et al. 1997; Cens et al. 1999; Walker et al.
1999). The C-terminus of the subunit interacts di-b4
rectly with the C-terminus of the subunit (Walkera1A
et al. 1998). Experimental deletion of 109 amino acids
from the C-terminus of the subunit eliminated bind-b4
ing to the C-terminus of the subunit and decreaseda1A
the time constant for the fast component of inactivation
(Walker et al. 1998). The R482X truncation mutant
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lacking the 38 C-terminal amino acids had a similar
effect on the time constant, indicating that these residues
are involved in the interaction with the C-terminus of
the subunit. The decrease in time constant observeda1A
with R482X would have the effect of increasing the rate
of channel inactivation and reducing the net inward
flow of calcium ions into activated neurons. This type
of effect may be quite pronounced during short and
rapid alterations in membrane potentials, such as those
that occur during action potentials, and could be of
clinical significance. The deletion of two consensus
phosphorylation sites in the R482X channel could also
have an effect on its activity (Hell et al. 1996; Chien et
al. 1998).
Although the C104F mutation did not alter channel
kinetics, other aspects of -subunit function may beb4
affected by this mutation. Replacement of cysteine with
a large hydrophobic phenylalanine residue in the C104F
mutation could disrupt the conformation of this do-
main, which is evolutionarily conserved and is thought
to be involved in interaction with other proteins (Walker
and De Waard 1998; Hanlon et al. 1999). Such inter-
actions could be crucial to channel clustering or tar-
geting without affecting the channel gating. The increase
in current amplitude observed for the mutant channels
could also contribute to abnormal firing properties.
The clinical features of individuals in pedigree C
closely resemble those of patients with mutations in the
calcium-channel subunit resulting in episodic ataxiaa1A
type 2 (EA2). The similarities include duration of at-
tacks, interictal imbalance and nystagmus, response to
acetazolamide, and apparently incomplete penetrance.
The only obvious difference is the earlier onset in in-
fancy in patients with EA2. The proband in family 3
was screened for mutations in the subunit by meansa1A
of SSCP, but no mutations were detected. The similar-
ities to EA2 are consistent with a causal role for the
C104F mutation in pedigree C.
The observation that the C104F mutation is associ-
ated with episodic ataxia in one family and with epi-
lepsy in another family suggests either that it is a neutral
polymorphism or that genetic and environmental fac-
tors modify the clinical effects of the mutation. The null
mutation of Cacnb4 in the lethargic mouse results in
seizures and ataxia, indicating that CACNB4 can con-
tribute to both phenotypes. Another mutation confer-
ring both episodic ataxia and susceptibility to seizures
was described in a human potassium channel (Zuberi
et al. 1999). We have recently mapped a genetic modifier
locus that dramatically alters the phenotype associated
with a sodium-channel mutation in mouse (Sprunger et
al. 1999). It would not be surprising if background ge-
netic variation in the human population could influence
the phenotypic consequences of ion-channel mutations
such as C104F.
Are the R482X and C104F mutations responsible for
the neurological disease in these pedigrees? The muta-
tions cosegregate with the disease in affected individ-
uals, are associated with phenotypes similar to those in
the mouse mutant, and are not present in 255 controls;
however, the functional alterations in the oocyte ex-
pression system are subtle, and the pedigrees are too
small to provide strong evidence for linkage. Iden-
tification of additional patients with mutations in
CACNB4 and demonstration of functional conse-
quences in a mammalian assay system could provide
additional support for a causal role for these mutations.
Because ataxia and epilepsy can result from mutations
in several different ion-channel genes, continued iden-
tification of disease-causing mutations will be a neces-
sary step toward the goal of developing therapies that
are tailored to each specific genetic disorder.
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Appendix
Clinical Features of Three Pedigrees with Coding
Variants of CACNB4
Beginning at age 9 years, the proband in pedigree A
experienced sporadic typical absences (brief spells of loss
of consciousness) and repetitive bilateral myoclonic jerks
in the shoulders and arms after awakening, without loss
of consciousness. She later experienced several GTCS,
usually within 1 h of awakening. Her epilepsy syndrome
was classified as JME (Commission on Classification and
Terminology of the International League Against Epi-
lepsy 1989). EEGs of the proband’s daughter showed
generalized 3/s spike-wave discharges without epileptic
seizures.
The affected father and son in pedigree B presented
with an atypical but similar clinical syndrome of idio-
pathic generalized epilepsy with rare juvenile atypical
prolonged absences and occasional GTCS. The proband
(individual I-1; fig. 3A) had normal intellectual and psy-
chomotor development. One febrile convulsion occurred
at age 3 years. After age 6 years, he had occasional
GTCS, predominantly on awakening, and, after age 12
years, occasional episodes of absence were described.
The interictal EEGs showed atypical generalized spike-
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wave discharges in the resting EEG. The ictal EEG was
highly unusual, with initial generalized desynchroniza-
tion and flattening, followed by irregular generalized
high-voltage delta activity interspersed with spikes and
wave. The syndrome was classified as idiopathic gen-
eralized epilepsy with GTCS on awakening, probable
absence seizures, and praxis-induced seizures. A pro-
longed atypical absence occurred in the the eldest son
(individual II-3) at age 14 years, while he was playing
cards. At age 17 years, he experienced GTCS shortly
after awakening. Two years later, he experienced a gen-
eralized tonic seizure while playing a complex strategic
game after sleep withdrawal. He experiences occasional
prolonged staring spells when lacking sleep. His inter-
ictal EEG presents some fast generalized spike-wave ac-
tivity (4–5 Hz) that increases with hyperventilation. In-
tellectual and psychomotor development was normal.
Both affected individuals report that seizures are precip-
itated by playing complex strategic games (praxis in-
duction), suggesting an unusual cognitive trigger of sei-
zure initiation (Inoue et al. 1992; Ritaccio 1994).
Clinical exploration revealed no evidence for epileptic
seizures in either the 51-year-old mother (individual II-
2) or the 17-year-old son (individual II-4). Individual II-
4 had normal EEG results.
After age 20 years, the proband in pedigree C (indi-
vidual III-13; fig. 3B) experienced recurrent episodes of
vertigo and ataxia that lasted for several hours. Interictal
examination revealed spontaneous downbeat and gaze-
evoked nystagmus and mild dysarthria and truncal
ataxia. The proband’s mother had identical episodes of
vertigo and ataxia after age 30 years as well as long-
standing dysarthria and imbalance. Acetazolamide pre-
vented the attacks in both the proband and mother, and
the attacks recurred when acetazolamide was briefly dis-
continued. A maternal aunt (individual II-10) has re-
ported mild episodes of ataxia for the past 5 years. Seven
years ago, another maternal aunt (individual II-9) ex-
perienced one prolonged episode of vertigo and imbal-
ance that lasted for several weeks. Although the pro-
band’s 12-year-old son (individual IV-16) had febrile
seizures as a child and exhibits dysarthria and imbalance,
he has not had episodes of vertigo or ataxia. The other
family members are asymptomatic, including individuals
II-3 and IV-17, both of whom carry the C104F mutation.
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